Cansortium Announces Exercise of Equity Cure Right

Rhea-AI Summary

Cansortium Inc. (OTCQX: CNTMF) announced the exercise of its first equity cure right under a $71 million credit agreement. The company will utilize proceeds from a recent $2.5 million equity private placement, completed on December 6, 2021, to enhance its EBITDA calculation for the Consolidated Interest Coverage Ratio, which must meet the threshold of 2.00:1.00. This equity cure right can be exercised for up to two consecutive quarters. Cansortium operates under the Fluent™ brand across multiple U.S. states, including Florida and Texas.

Positive

• Exercise of equity cure right strengthens financial position.
• Successful $2.5 million equity private placement supports EBITDA calculations.

Negative

• None.

MIAMI, Dec. 9, 2021 /CNW/ - Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated cannabis company operating under the Fluent™ brand, today provided notice that it has exercised its first equity cure right under its previously announced $71 Million Credit Agreement.

The net proceeds from its US$2.5 million equity private placement announced on December 6, 2021 will be deemed to have occurred during the quarter ended September 30, 2021 for purposes of EBITDA used in the calculation of the Consolidated Interest Coverage Ratio, which is required to be 2.00:1.00. The Company is entitled to exercise its equity cure right for up to two consecutive quarters.

No securities regulatory authority has either approved or disapproved of the contents of this news release. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of Cansortium in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Cansortium Inc.
Cansortium is a vertically-integrated cannabis company with licenses and operations in Florida, Pennsylvania, Michigan and Texas. The Company operates under the Fluent™ brand and is dedicated to being one of the highest quality cannabis companies for the communities it serves. This is driven by Cansortium's unrelenting commitment to operational excellence in cultivation, production, distribution and retail. The Company is headquartered in Miami, Florida.

Cansortium Inc.'s common shares trade on the CSE under the symbol "TIUM.U" and on the OTCQX Best Market under the symbol "CNTMF". For more information about the Company, please visit www.getfluent.com.

Forward-Looking Information
Certain information in this news release may constitute forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates, and projections regarding future events.

Forward-looking information is necessarily based on many opinions, assumptions, and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in the public documents of the Company available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

Company Contact
Robert Beasley, CEO
(305) 900-6266
www.getfluent.com

Investor Relations Contact
Sean Mansouri, CFA
Elevate IR
(949) 200-4603
investors@cansortium.com

Media Contact
Julie Dietel
Grasslands: A Journalism-Minded Agency 
(978) 502-7705
julie@mygrasslands.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cansortium-announces-exercise-of-equity-cure-right-301441781.html

SOURCE Cansortium Inc

FAQ

What is Cansortium Inc.'s recent financial announcement about?

Cansortium Inc. announced the exercise of its equity cure right to improve its financial metrics related to a $71 million credit agreement.

How does the equity cure right affect Cansortium's interest coverage ratio?

The equity cure right allows Cansortium to use proceeds from a $2.5 million private placement to meet the required Consolidated Interest Coverage Ratio of 2.00:1.00.

What was the amount raised in Cansortium Inc.'s private placement?

Cansortium Inc. raised $2.5 million through a recent equity private placement.

When was the equity private placement announced for Cansortium Inc.?

The equity private placement was announced on December 6, 2021.

What is the stock symbol for Cansortium Inc.?

Cansortium Inc. trades under the stock symbol CNTMF on the OTCQX Best Market.